Vectura Fertin Pharma
Michael J Donnelly is an experienced finance and operations executive currently serving as U.S. Pharma CFO and Head of Operations at Vectura Fertin Pharma since February 2022, with executive accountability for finance functions and governance. Prior to this role, Michael held multiple positions at Optinose, including Vice President of Business Insights, where responsibilities expanded to business development and finance, and Executive Director of Commercial Insights & Analytics, focusing on market research and analytics. Michael's extensive background at Novartis included various director-level roles across marketing, sales operations, and analytics, emphasizing strategic planning and functional improvements. Earlier in the career, Michael contributed to Johnson & Johnson in multiple managerial positions, providing financial leadership and analysis across several divisions. Michael earned a Master of Business Administration from Villanova University and a Bachelor's Degree in Accounting from Rutgers University.
This person is not in any offices
Vectura Fertin Pharma
1 followers
We aim to be a leader in the health and wellness space by developing a pipeline of proprietary products that we can commercialize. Our mission is to enhance life through the delivery of seamless health experiences. Vectura Fertin Pharma brings together Vectura’s expertise in inhalation and Fertin Pharma’s leadership in oral and intra-oral delivery systems to build upon products that exist today and make them better for consumers and patients tomorrow. We will take proven, safe, and effective therapies, unlock their true potential through the application of new and existing consumer and patient-led delivery systems, and commercialize them through proprietary wellness and healthcare brands or in partnership with other pharmaceutical companies. For more, visit our website at https://www.vecturafertinpharma.com.